Previous close | 23.27 |
Open | 23.41 |
Bid | 23.13 x 400 |
Ask | 23.19 x 600 |
Day's range | 22.96 - 23.51 |
52-week range | 13.82 - 25.95 |
Volume | |
Avg. volume | 751,130 |
Market cap | 2.096B |
Beta (5Y monthly) | 1.97 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 15, 2024, Paul Diaz, President and Chief Executive Officer of Myriad Genetics Inc (NASDAQ:MYGN), executed a significant transaction by selling 227,844 shares of the company.
On May 13, 2024, Director Lee Newcomer sold 6,200 shares of Myriad Genetics Inc (NASDAQ:MYGN) as reported in a recent SEC Filing.
As you might know, Myriad Genetics, Inc. ( NASDAQ:MYGN ) just kicked off its latest first-quarter results with some...